Back to search
Postmenopausal Women With Osteoporosis at High Risk of Fracture
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Postmenopausal Women With Osteoporosis at High Risk of Fracture trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Postmenopausal Women With Osteoporosis at High Risk of Fracture trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This is a multicenter, randomized, open-label, parallel-controlled Phase II study designed to evaluate the differences in safety among four different dosing reg…
This study is a multicenter, randomized, double-blind comparative study to valuating the efficacy and safety of QL1206 and Prolia® in postmenopausal women with…
The primary objective of this study is to evaluate the safety and tolerability of human umbilical cord-derived mesenchymal stem cells for injection (HMM910 ) in…
The primary objective of this study is to characterize safety and tolerability of romosozumab in postmenopausal women with osteoporosis and a high risk of fract…